Implications of pharmacogenetics for individualizing drug treatment and for study design. - Wikidata - awgldk - TriplyDB

Implications of pharmacogenetics for individualizing drug treatment and for study design.

Implications of pharmacogenetics for individualizing drug treatment and for study design.

http://www.wikidata.org/entity/Q35102211

about

Toxicity of amphetamines: an update Pharmacogenomics and drug response in cardiovascular disorders Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview.Using pharmacogenetics to understand adverse drug reactions in children.Pharmacogenetics of lipid diseases.Pharmacogenomics in early-phase clinical development Pharmacogenomics in cardiovascular disease: the role of single nucleotide polymorphisms in improving drug therapy.AAPS/RAPS/CAPRA collaborative program: exploring the challenges of drug regulation in a global environment: clinical concerns.Pharmacogenetics of statins: achievements, whole-genome analyses and future perspectives.Pediatric perspective on pharmacogenomics.Pharmacogenomics and pharmacogenetics for the intensive care unit: a narrative review.Genetic variants associated with cisplatin-induced hearing loss.

P2860

Q22252794-0A391C49-A470-450A-916C-675EA261105F Q28171051-D27FBE4C-10EB-4649-8F98-00FF30B8997E Q34976260-4EF65B54-BA5E-4831-809F-ACAC797A3607 Q35572602-BEA5F877-4BD6-42A5-A0C8-8590BD378570 Q35985478-400C1C52-C0C7-4701-A2C1-EDA48A6B8732 Q36001208-CDA130CF-4744-4A56-BA1A-642E89EDE5DF Q36326202-0840D0DB-03FD-48B2-B443-335983CD693E Q37361487-AC1E53C7-2EAE-4100-86AE-2041DC836575 Q38010751-F5368084-B3E8-4986-A640-0AA8DD75962A Q38162869-EC05C781-E7E6-412E-9D1A-4F5533F631C3 Q38983589-9A100D8E-7616-4717-AF4A-CB1A83063089 Q50437494-74F3D773-1746-48D8-9B54-E4C19E40AE7C

P2860

Implications of pharmacogenetics for individualizing drug treatment and for study design.

http://www.wikidata.org/entity/Q35102211

description

2003 nî lūn-bûn

@nan

2003 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի մարտին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Implications of pharmacogenetics for individualizing drug treatment and for study design.

@ast

Implications of pharmacogenetics for individualizing drug treatment and for study design.

@en

type

label

Implications of pharmacogenetics for individualizing drug treatment and for study design.

@ast

Implications of pharmacogenetics for individualizing drug treatment and for study design.

@en

prefLabel

Implications of pharmacogenetics for individualizing drug treatment and for study design.

@ast

Implications of pharmacogenetics for individualizing drug treatment and for study design.

@en

P1433

Q35102211-5BAF7652-0D3D-41CF-BC79-F6D6D5AC33E4

P1476

Q35102211-D310E9E4-8C10-41ED-87E7-CB9345CB354B

P2093

Q35102211-31BBA7D8-5E28-48EB-8CDD-A4756FAC4B97

Q35102211-3228DD85-D578-447A-9F72-1C8776521C9C

Q35102211-4EABFD63-1734-4CA9-BFB4-DCC12C40312D

Q35102211-5BE2DD79-1B98-431D-9FF5-ADFE23A24338

Q35102211-667A4CA3-F7D3-4A2E-A567-150599001B1B

Q35102211-7AB418A9-7B46-4410-A89E-2154D9832A73

Q35102211-E3A8379B-6E14-42CF-AB56-7A1417233EB9

P2860

Q35102211-02743748-2491-479B-A6DA-7EE15B5FF4D7

Q35102211-03A87978-A738-42D2-9183-2A698B1F11DC

Q35102211-0A4BC499-2ADA-4580-B299-FF7388F269AD

Q35102211-0C34CCB7-C157-4F4D-9DCC-B8E4B3351DED

Q35102211-0DF9D52E-CF39-4F8D-9993-AC58C9E9DE61

Q35102211-0EF9A4AE-2269-41CF-ABD6-710D13AD74F8

Q35102211-0F0D13CF-0CB4-4F7B-B1F9-D008DD01468A

Q35102211-13EFF413-AC6B-4261-B468-FE9420A1366E

Q35102211-1A72C6E6-A6D6-466B-AD02-3994B5639482

Q35102211-1B95CF26-E35A-4F47-8810-1F72833E7DC2

P2888

Q35102211-29311C4A-0AC2-4F8B-B4B8-B5CD04444060

P304

Q35102211-F409838E-AEF8-421F-9F7B-A98FC332C61A

P31

Q35102211-6A4ADD44-B97D-4D36-B742-431B29AC4F50

P356

Q35102211-F736FB26-33B0-4A90-867F-3389F8896203

P433

Q35102211-E9F4C344-6D4D-4D76-A667-C191557C76A4

P478

Q35102211-69C7728D-16D3-43C3-A1FA-37FAF5908544

P577

Q35102211-FCBB72E6-0E5C-437E-90A4-CB9AC0257EC7

P5875

Q35102211-BDEEAF9F-6DB9-4907-B839-44896AB93030

P698

Q35102211-14D82773-4A46-41D2-85B3-D49F02F11DA5

P356

S00109-002-0417-4

P1433

Journal of Molecular Medicine

P1476

Implications of pharmacogenetics for individualizing drug treatment and for study design.

@en

P2093

Christian Meisel

http://www.w3.org/2001/XMLSchema#string

Ivar Roots

http://www.w3.org/2001/XMLSchema#string

Julia Kirchheiner

http://www.w3.org/2001/XMLSchema#string

Jürgen Brockmöller

http://www.w3.org/2001/XMLSchema#string

Przemyslaw M Mrozikiewicz

http://www.w3.org/2001/XMLSchema#string

Przemyslaw Niewinski

http://www.w3.org/2001/XMLSchema#string

Thomas Gerloff

http://www.w3.org/2001/XMLSchema#string

P2860

Association of a human G-protein beta3 subunit variant with hypertension

Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues

Cytochrome P4502C9: an enzyme of major importance in human drug metabolism

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents.

A common polymorphism associated with antibiotic-induced cardiac arrhythmia

Polymorphisms of alpha-adducin and salt sensitivity in patients with essential hypertension

A 2.4-megabase physical map spanning the CYP2C gene cluster on chromosome 10q24

Frequency of cytochrome P450 CYP2C9 variants in a Turkish population and functional relevance for phenytoin

Pharmacokinetics of chlorpheniramine, phenytoin, glipizide and nifedipine in an individual homozygous for the CYP2C9*3 allele

Intestinal secretion of intravenous talinolol is inhibited by luminal R-verapamil

P2888

s00109-002-0417-4

P304

154-167

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00109-002-0417-4

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

81

http://www.w3.org/2001/XMLSchema#string

P577

2003-03-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10815547

http://www.w3.org/2001/XMLSchema#string

P698

12682724

http://www.w3.org/2001/XMLSchema#string